Detalles de la búsqueda
1.
Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
Biol Blood Marrow Transplant
; 21(5): 829-39, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25617806
2.
Beneficial effect of the CXCL12-3'A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors.
Cytokine
; 76(2): 182-186, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25982843
3.
NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(3): 409-14, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24345423
4.
Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.
Am J Hematol
; 89(10): E176-83, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25044365
5.
Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients.
Front Immunol
; 12: 658896, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34149697
6.
CD14 + HLADR - blood values in patients after alloHSCT are highly predictive of survival and infectious complications.
Transpl Immunol
; 65: 101370, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33484872
7.
CCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donor.
Br J Haematol
; 171(2): 285-288, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25823722
8.
Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.
PLoS One
; 13(12): e0209108, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30521628
9.
The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.
PLoS One
; 13(1): e0190525, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29304116
10.
Intra-bone donor lymphocyte infusion at relapse: clinical outcome is associated with presence of CD8+ cells in the marrow.
Bone Marrow Transplant
; 55(5): 974-978, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31455896
11.
Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.
Viruses
; 7(3): 1391-408, 2015 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25807050
12.
Donor lymphocyte infusions to leukemic bone lesions are therapeutically effective in a Ph+ ALL patient with post-HSCT relapse.
J Immunotoxicol
; 11(4): 347-52, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24611731
13.
Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
Transplantation
; 86(7): 968-76, 2008 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18852664
Resultados
1 -
13
de 13
1
Próxima >
>>